Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;17(3):133-140.
doi: 10.11909/j.issn.1671-5411.2020.03.009.

Association of serum lipoprotein(a) level with the severity and prognosis of calcific aortic valve stenosis: a Chinese cohort study

Affiliations

Association of serum lipoprotein(a) level with the severity and prognosis of calcific aortic valve stenosis: a Chinese cohort study

Shuo-Lin Liu et al. J Geriatr Cardiol. 2020 Mar.

Abstract

Background: There was a causal relationship between elevated lipoprotein(a) [Lp(a)] levels and increased risk of calcific aortic valve stenosis (CAVS) in whites and blacks. The present study aimed to investigate whether Lp(a) levels were associated with aortic stenosis (AS) severity and clinical events in Chinese patients.

Methods: Levels of serum Lp(a) were measured in 652 patients with CAVS, whom all underwent baseline echocardiographic examination. The clinical endpoint was defined as a composite of aortic valve replacement (AVR) and cardiac death.

Results: Patients in the tertile 3 of Lp(a) had a higher percentage of severe AS compared with those in the tertile 1 and 2 of Lp(a) (46.2% vs. 33.9%, P = 0.005). Moreover, the top tertile of Lp(a) was an independent predictor of severe AS (OR = 1.78, 95% CI: 1.18-2.66, P = 0.006). However, there was no significant association between tertile 3 of Lp(a) and clinical events (hazard ratio: 0.73; 95% CI: 0.43-1.24; P = 0.239) in the multivariate Cox regression analysis during a mean follow-up time of 3.16 ± 2.74 years.

Conclusions: Elevated Lp(a) level was an independent predictor of severe AS by echocardiography in the Chinese population, but was not associated with the increased risk of AVR and cardiac death, suggesting that Lp(a) levels might be helpful in the risk stratification of patients with CAVS.

Keywords: Aortic stenosis; Calcification; Lipoprotein(a); Prognosis; Severity.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. The flow chart of the current study.
AS: aortic stenosis; AVR: aortic valve replacement; CAVS: calcific aortic valve stenosis.
Figure 2.
Figure 2.. Distribution of Lp(a) levels in the total population.
AS: aortic stenosis; CAVS: calcific aortic valve stenosis; Lp(a): lipoprotein(a); Vpeak: peak aortic valve velocity.
Figure 3.
Figure 3.. The percentages of severe AS according to plasma Lp(a) levels.
AS: aortic valve stenosis; BMI: body mass index; LDL-C: low density lipoprotein-cholesterol; Lp(a): lipoprotein(a).
Figure 4.
Figure 4.. Multivariate Cox regression analysis for AVR and cardiac death.
AS: aortic stenosis; AVR: aortic valve replacement; BMI: body mass index; LDL-C: low density lipoprotein-cholesterol.
Figure 5.
Figure 5.. The event-free Survival analysis according to lipoprotein(a) [Lp(a)] levels for aortic valve replacement and cardiac death.
Lp(a): lipoprotein(a).

Similar articles

Cited by

References

    1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–1011. - PubMed
    1. d'Arcy JL, Coffey S, Loudon MA, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J. 2016;37:3515–3522. - PMC - PubMed
    1. Lindman BR, Clavel MA, Mathieu P, et al. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006. - PMC - PubMed
    1. Zhao Y, Nicoll R, He YH, et al. The effect of statins on valve function and calcification in aortic stenosis: a meta-analysis. Atherosclerosis. 2016;246:318–324. - PubMed
    1. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol. 2007;49:554–561. - PMC - PubMed

LinkOut - more resources